Susan Kuo is a postdoctoral fellow in Elise Robinson’s lab at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts.
![Susan Kuo headshot](https://www.thetransmitter.org/wp-content/uploads/2022/08/th-2090583122.jpg)
Susan Kuo
Postdoctoral fellow
Broad Institute of MIT and Harvard
From this contributor
What developmental milestones say about autism research: A conversation with Susan Kuo and Elise Robinson
Shifts in diagnostic criteria have only added to the condition’s bedeviling heterogeneity, an analysis of smiling, sitting, walking and other early milestones in more than 17,000 autistic children reveals.
![Toddler stepping towards parent, in front of window.](https://www.thetransmitter.org/wp-content/uploads/2022/08/844-autism-developmental-variability.jpg)
What developmental milestones say about autism research: A conversation with Susan Kuo and Elise Robinson
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.